Adaptive Biotechnologies Earnings Estimate

By analyzing Adaptive Biotechnologies' earnings estimates, investors can diagnose different trends across Adaptive Biotechnologies' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Adaptive Biotechnologies Corp is based on EPS before non-recurring items and includes expenses related to employee stock options. Adaptive Biotechnologies is projected to generate -0.21 in earnings per share on the 31st of December 2025. Adaptive Biotechnologies earnings estimates show analyst consensus about projected Adaptive Biotechnologies Corp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Adaptive Biotechnologies' historical volatility. Many public companies, such as Adaptive Biotechnologies, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Adaptive Biotechnologies' earnings estimates, investors can diagnose different trends across Adaptive Biotechnologies' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to gain to 0.73 in 2025, whereas Gross Profit is likely to drop slightly above 86.8 M in 2025. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.